MedTrace Logo

Pilot Trial of Mobile Technology for Adolescent Suicidality

NCT06454136 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 228

Last updated 2025-11-05

No results posted yet for this study

Summary

The primary objective of this study is to assess the efficacy of a digital intervention in reducing suicidal ideation in adolescents.

Conditions

Interventions

DEVICE

OTX-207

Experimental Pscyhoeducation and Intervention App

DEVICE

Comparator App + Treatment as Usual (TAU)

Digitized content and information included in standard of care (i.e., TAU)

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Oui Therapeutics, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-23
Primary Completion
2026-06-30
Completion
2027-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06454136 on ClinicalTrials.gov